Effect of combined treatment of shuanghuanglian and recombinant interferon α2a on coxsackievirus B3 replication in vitro

Zhongguo Zhongyao Zazhi

Volumn 25, Issue 11, 2000, Pages 684-

  Lu, Hai Tao ^a   Yang, Ji Cheng ^b   Yuan, Zhi Chang ^a   Sheng, Wei Hua ^b   Yan, Weng Hua ^a  

^a Department of Respiratory Medicine   (China)

^b Department of Radiation Medicine   (China)

Author keywords

2a; Coxsackievirus B3 (CVB3); rIFN ; Shuanghuanglian

Indexed keywords

ALPHA2A INTERFERON; ANTIVIRUS AGENT; HERBACEOUS AGENT;

ARTICLE; DRUG COMBINATION; DRUG EFFECT; DRUG POTENTIATION; ENTEROVIRUS; HUMAN; MEDICINAL PLANT; VIRUS REPLICATION;

ANTIVIRAL AGENTS; DRUG COMBINATIONS; DRUG SYNERGISM; DRUGS, CHINESE HERBAL; ENTEROVIRUS B, HUMAN; HUMANS; INTERFERON ALFA-2A; PLANTS, MEDICINAL; VIRUS REPLICATION;

EID: 23744496533     PISSN: 10015302     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (12)

1. Conaldi P G, Serra C, Mossa A, et al. Persistent Infection of Human Vascular Endothelial Cells by Group B Coxsackieviruses. J Infect Dis, 1997,175(3):693.
2. 3 Replication. J Lab Clin Mcd, 1992,120(4):569.
3. Jazn C. Combined Interaction of Antiherpes Substance and Interferon P on the Multiplication of Herpes Simplex Virus. Arch Virol, 1982,73:135.
4. Berenbaum M C. A Method for Testing for Synergy with Any Number of Agents. J Infect Dis, 1978,137:122.